JP Patent

JP5640065B2 — 薬学的処方物：８−［｛１−（３，５−ビス−（トリフルオロメチル）フェニル）−エトキシ｝−メチル］−８−フェニル−１，７−ジアザ−スピロ［４．５］デカン−２−オンの塩およびそれを使用した処置方法

Assigned to オプコ ヘルス， インコーポレイテッド · Expires 2014-12-10 · 11y expired

What this patent protects

Patent listed against rolapitant-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5640065B2
Jurisdiction
JP
Classification
—
Expires
2014-12-10
Drug substance claim
No
Drug product claim
No
Assignee
オプコ ヘルス， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.